Vanda Pharmaceuticals
VNDA
#7905
Rank
NZ$0.60 B
Marketcap
NZ$10.11
Share price
0.17%
Change (1 day)
33.52%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -NZ$0.21 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.21 Billion. In 2024 the company made an earning of -NZ$69.91 Million a decrease over its 2023 earnings that were of -NZ$23.99 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.21 Billion197.2%
2024 -NZ$69.91 Million191.43%
2023 -NZ$23.99 Million-320.45%
2022 NZ$10.88 M-84.99%
2021 NZ$72.49 M54.8%
2020 NZ$46.82 M19.42%
2019 NZ$39.21 M4.93%
2018 NZ$37.37 M-228.6%
2017 -NZ$29.06 Million-8.98%
2016 -NZ$31.93 Million-53.79%
2015 -NZ$69.09 Million-30.18%
2014 -NZ$98.95 Million173.08%
2013 -NZ$36.24 Million-25.33%
2012 -NZ$48.53 Million163.61%
2011 -NZ$18.41 Million-221.15%
2010 NZ$15.19 M-124.53%
2009 -NZ$61.95 Million-29.44%
2008 -NZ$87.79 Million-36.2%
2007 -NZ$0.14 Billion21.81%
2006 -NZ$0.12 Billion170.55%
2005 -NZ$41.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.66 B-21,553.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.13 B-13,134.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$18.20 B-8,846.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.51 B-25,803.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.61 B-10,960.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.49 B-8,025.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-NZ$4.83 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA